Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801972810> ?p ?o ?g. }
- W2801972810 abstract "Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective treatment. The epithelial-mesenchymal transition (EMT) is a critical stage during the development of fibrosis. To assess the effect of sulforaphane (SFN) on the EMT and fibrosis using an in vitro transforming growth factor (TGF)-β1-induced model and an in vivo bleomycin (BLM)-induced model. In vitro studies, cell viability, and cytotoxicity were measured using a Cell Counting Kit-8. The functional TGF-β1-induced EMT and fibrosis were assessed using western blotting and a quantitative real-time polymerase chain reaction. The lungs were analyzed histopathologically in vivo using hematoxylin and eosin and Masson’s trichrome staining. The BLM-induced fibrosis was characterized by western blotting and immunohistochemical analyses for fibronectin, TGF-β1, E-cadherin (E-cad), and α-smooth muscle actin (SMA) in lung tissues. SFN reversed mesenchymal-like changes induced by TGF-β1 and restored cells to their epithelial-like morphology. The results confirmed that the expression of the epithelial marker, E-cadherin, increased after SFN treatment, while expression of the mesenchymal markers, N-cadherin, vimentin, and α-SMA decreased in A549 cells after SFN treatment. In addition, SFN inhibited TGF-β1-induced mRNA expression of the EMT-related transcription factors, Slug, Snail, and Twist. The SFN treatment attenuated TGF-β1-induced expression of fibrosis-related proteins, such as fibronection, collagen I, collagen IV, and α-SMA in MRC-5 cells. Furthermore, SFN reduced the TGF-β1-induced phosphorylation of SMAD2/3 protein in A549 cells and MRC-5 cells. BLM induced fibrosis in mouse lungs that was also attenuated by SFN treatment, and SFN treatment decreased BLM-induced fibronectin expression, TGF-β1 expression, and the levels of collagen I in the lungs of mice. SFN showed a significant anti-fibrotic effect in TGF-β-treated cell lines and BLM-induced fibrosis in mice. These findings showed that SFN has anti-fibrotic activity that may be considered in the treatment of IPF." @default.
- W2801972810 created "2018-05-17" @default.
- W2801972810 creator A5007789858 @default.
- W2801972810 creator A5013860466 @default.
- W2801972810 creator A5041272233 @default.
- W2801972810 creator A5061391906 @default.
- W2801972810 creator A5062281865 @default.
- W2801972810 creator A5063736270 @default.
- W2801972810 creator A5078539188 @default.
- W2801972810 date "2018-04-02" @default.
- W2801972810 modified "2023-10-17" @default.
- W2801972810 title "Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition" @default.
- W2801972810 cites W1498451757 @default.
- W2801972810 cites W1964081206 @default.
- W2801972810 cites W1966630775 @default.
- W2801972810 cites W1967101785 @default.
- W2801972810 cites W1993559550 @default.
- W2801972810 cites W2005859751 @default.
- W2801972810 cites W2014687097 @default.
- W2801972810 cites W2018809578 @default.
- W2801972810 cites W2033367275 @default.
- W2801972810 cites W2035653659 @default.
- W2801972810 cites W2041112507 @default.
- W2801972810 cites W2054017711 @default.
- W2801972810 cites W2065977597 @default.
- W2801972810 cites W2094850025 @default.
- W2801972810 cites W2104850609 @default.
- W2801972810 cites W2109052128 @default.
- W2801972810 cites W2114330584 @default.
- W2801972810 cites W2135863640 @default.
- W2801972810 cites W2136068980 @default.
- W2801972810 cites W2138871107 @default.
- W2801972810 cites W2151012390 @default.
- W2801972810 cites W2166396920 @default.
- W2801972810 cites W2167383172 @default.
- W2801972810 cites W2168666423 @default.
- W2801972810 cites W2170331002 @default.
- W2801972810 cites W2599075603 @default.
- W2801972810 cites W2608704879 @default.
- W2801972810 cites W2610483591 @default.
- W2801972810 cites W4211233744 @default.
- W2801972810 doi "https://doi.org/10.1186/s40360-018-0204-7" @default.
- W2801972810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5879815" @default.
- W2801972810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29609658" @default.
- W2801972810 hasPublicationYear "2018" @default.
- W2801972810 type Work @default.
- W2801972810 sameAs 2801972810 @default.
- W2801972810 citedByCount "62" @default.
- W2801972810 countsByYear W28019728102018 @default.
- W2801972810 countsByYear W28019728102019 @default.
- W2801972810 countsByYear W28019728102020 @default.
- W2801972810 countsByYear W28019728102021 @default.
- W2801972810 countsByYear W28019728102022 @default.
- W2801972810 countsByYear W28019728102023 @default.
- W2801972810 crossrefType "journal-article" @default.
- W2801972810 hasAuthorship W2801972810A5007789858 @default.
- W2801972810 hasAuthorship W2801972810A5013860466 @default.
- W2801972810 hasAuthorship W2801972810A5041272233 @default.
- W2801972810 hasAuthorship W2801972810A5061391906 @default.
- W2801972810 hasAuthorship W2801972810A5062281865 @default.
- W2801972810 hasAuthorship W2801972810A5063736270 @default.
- W2801972810 hasAuthorship W2801972810A5078539188 @default.
- W2801972810 hasBestOaLocation W28019728101 @default.
- W2801972810 hasConcept C104317684 @default.
- W2801972810 hasConcept C121608353 @default.
- W2801972810 hasConcept C126322002 @default.
- W2801972810 hasConcept C142724271 @default.
- W2801972810 hasConcept C194232998 @default.
- W2801972810 hasConcept C198826908 @default.
- W2801972810 hasConcept C2779013556 @default.
- W2801972810 hasConcept C2780559512 @default.
- W2801972810 hasConcept C2780841255 @default.
- W2801972810 hasConcept C2781244666 @default.
- W2801972810 hasConcept C502942594 @default.
- W2801972810 hasConcept C55493867 @default.
- W2801972810 hasConcept C60644358 @default.
- W2801972810 hasConcept C71924100 @default.
- W2801972810 hasConcept C76419328 @default.
- W2801972810 hasConcept C86803240 @default.
- W2801972810 hasConcept C98274493 @default.
- W2801972810 hasConceptScore W2801972810C104317684 @default.
- W2801972810 hasConceptScore W2801972810C121608353 @default.
- W2801972810 hasConceptScore W2801972810C126322002 @default.
- W2801972810 hasConceptScore W2801972810C142724271 @default.
- W2801972810 hasConceptScore W2801972810C194232998 @default.
- W2801972810 hasConceptScore W2801972810C198826908 @default.
- W2801972810 hasConceptScore W2801972810C2779013556 @default.
- W2801972810 hasConceptScore W2801972810C2780559512 @default.
- W2801972810 hasConceptScore W2801972810C2780841255 @default.
- W2801972810 hasConceptScore W2801972810C2781244666 @default.
- W2801972810 hasConceptScore W2801972810C502942594 @default.
- W2801972810 hasConceptScore W2801972810C55493867 @default.
- W2801972810 hasConceptScore W2801972810C60644358 @default.
- W2801972810 hasConceptScore W2801972810C71924100 @default.
- W2801972810 hasConceptScore W2801972810C76419328 @default.
- W2801972810 hasConceptScore W2801972810C86803240 @default.
- W2801972810 hasConceptScore W2801972810C98274493 @default.
- W2801972810 hasFunder F4320323639 @default.
- W2801972810 hasIssue "1" @default.
- W2801972810 hasLocation W28019728101 @default.